Rotolabel invests in Rotocontrol booklet and pharmaceutical inspection machines

Sale and installation of machines for the South African printer was managed by ROTOCON

LINAU, Germany (October 11, 2016) - South African printer Rotolabel recently invested for pharmaceutical booklet growth with the combined investment of two ROTOCONTROL machines. Purchased was a BL440 series high-speed booklet machine combined with an RSP-H series 100% pharmaceutical inspection machine, in addition to a vision system from AVT. Managing the sale and installation was ROTOCON, the local agent for ROTOCONTROL and AVT in South Africa.

With operation speed up to 65m/min, the ROTOCONTROL BL440 series produces booklet labels with variable scopes and formats, featuring large diameter idler rollers, a direct web path, and web widths up to 510 mm. The ROTOCONTROL RSP-H series is specifically designed for compliance of demanding security label inspection and finishing applications. Also included in the sale was an AVT Helios vision system providing advanced 100% automatic label inspection and quality assurance. The combination of the three components provides Rotolabel an end-to-end solution for the inspection and finishing of high quality and competitively priced booklet labels.

Founded in 1982, and acquired by the Bidvest Group in 2008, Rotolabel is a leading supplier of labelling solutions in southern Africa. Their new booklet and inspection finishing solution from ROTOCONTROL and AVT will be primarily used to broaden the finishing of their pharmaceutical 'xpandalabel™' booklet labels in their Johannesburg factory where 100% compliance is mandatory.

Khorommbi Nelwamondo, general manager of Rotolabel comments: "After an evaluation of our business and market, it was evident that investing in growing our pharmaceutical offering, specifically our xpandalabel™ line of booklet labels was advantageous. ROTOCON presented the ROTOCONTROL pharmaceutical booklet finishing capabilities with the integration of the AVT inspection system as a valuable combination. With this solution now fully operational, we have a powerful pharmaceutical offering for the growing demand of the South Africa market, and are fully supported locally by ROTOCON through their expanded new location in Johannesburg."